The fundamental concept of cloning posits the creation of a genetically identical replica. However, a comprehensive two-decade study has challenged this assumption, revealing that cloned organisms, often referred to as clones, accumulate a significant number of additional mutations. This accumulation can escalate to critical, even lethal, levels with successive generations of cloning.
These discoveries carry substantial implications across various fields. They affect the application of cloning within agricultural practices and in conservation efforts aimed at preserving endangered species. Furthermore, the findings shed light on the potential utility of cloning technologies for human applications.
A primary inquiry arising from this research concerns the reason behind the elevated mutation rates observed in clones. One hypothesis suggests that somatic cells, those used in the cloning process sourced from adult organisms, may naturally accumulate more mutations than germline cells (eggs or sperm). However, Teruhiko Wakayama of Yamanashi University in Japan proposes that the cloning procedure itself might be responsible for at least some of these genetic alterations.
“Unfortunately, while clones were once thought to be identical to the original, it has become clear that this is not the case, suggesting that there may be issues with their use,” stated Wakayama. He further emphasized the necessity of future research to “demonstrate that mutations arising from cloning do not pose problems.”
The Breakthrough and Subsequent Investigations
The successful cloning of mammals was once considered an insurmountable scientific hurdle. This was largely due to the complex process of cellular specialization, where cells develop and differentiate, undergoing modifications to their genome. These modifications include the addition or removal of chemical tags that regulate gene expression. For instance, the DNA of a skin cell is specifically “programmed” to function as a skin cell.
The advent of Dolly the sheep in July 1996 marked a pivotal moment. Her birth demonstrated that by transferring the nucleus from an adult somatic cell into an enucleated egg cell, the genomic material could be reprogrammed. This reprogramming allowed the egg to develop into a viable embryo. Following this landmark achievement, Wakayama succeeded in creating Cumulina, the first cloned mouse, in October 1997.
To rigorously assess the efficacy of his team’s mouse-cloning methodology, Wakayama initiated a series of experiments in 2005 involving the cloning of clones. He explained his motivation: “Just as copying a painting results in lower image quality, I wanted to verify how clones compare to the original.”
Generational Cloning and Observed Outcomes
In 2013, Wakayama and his research collaborators announced a significant achievement: they had successfully cloned clones for 25 consecutive generations. This extensive process yielded over 500 mice derived from the initial donor mouse. At the time of this announcement, Wakayama reported that the cloned mice generated through their experiments exhibited no physical abnormalities across any generation. They lived for comparable durations to naturally reproduced mice and maintained good health.
However, this level of consistent success has not been replicated across all species. Cloned dogs, for example, still face a high incidence of health issues. Furthermore, no primate has yet been successfully cloned from an adult cell. Despite these challenges, Wakayama initially believed that repeated cloning in mice could continue indefinitely.
Yet, as the experimental work progressed, the team observed a decline in the success rate. Ultimately, by the 58th generation, none of the cloned mice survived. This outcome prompted a deeper investigation into the underlying causes.
Genome Sequencing and Identification of Mutations
To understand the reasons behind the failure in later generations, the research team undertook a comprehensive sequencing of the genomes of 10 mice from various generations. This analysis revealed a striking difference: an average of over 70 mutations per clone generation. This figure is three times higher than that observed in a control group of mice that reproduced through natural means.
A particularly concerning observation was the accumulation of large-scale mutations in the cloned mice after the 27th generation. In one extreme case, an entire X chromosome was lost. This finding suggested a progressive degradation of genetic integrity with each cloning cycle.
Hypotheses on Mutation Origins
Several explanations have been proposed to account for the increased mutation burden. A straightforward hypothesis suggests that natural biological processes inherently protect sperm and egg cells from mutations. Additionally, mechanisms exist within sexual reproduction to eliminate harmful mutations. Consequently, adult somatic cells, which are utilized in cloning, naturally harbor a greater number of accumulated mutations.
Recent research supports this, indicating that mutations may accumulate approximately eight times faster in blood cells compared to sperm cells. Therefore, if the somatic cells used for cloning already possess more mutations, it logically follows that the resulting clones will also exhibit a higher mutation load.
However, Wakayama also contends that the nuclear transfer process itself contributes to the observed increase in mutations. He commented, “It is not surprising that the nucleus – that is, the DNA – might be damaged by the physical shock.” He expressed hope that “if we could develop a gentler method of nuclear transfer, we might be able to reduce the mutation rate in cloned embryos.” Despite this belief, he acknowledged the current lack of a clear path to achieving such a method.
Skepticism and Practical Considerations
Shoukhrat Mitalipov of Oregon Health & Science University offers a more cautious perspective. He suggests that “any observed increase in mutation rates in clones is more likely to reflect the genomic state of the donor cells, rather than a uniform effect of the nuclear transfer process itself.” This viewpoint prioritizes the inherent genetic condition of the starting material over the act of cloning as the primary driver of mutations.
While human cloning is prohibited in numerous countries, researchers like Mitalipov are actively exploring the application of nuclear transfer for therapeutic purposes. These applications include the generation of compatible tissues or organs for medical treatments and the development of sperm and egg cells to address infertility.
Mitalipov highlights that Wakayama’s findings underscore the critical importance of rigorous donor cell selection and screening in these contexts. He advises that “ideally, donor cell populations should be evaluated for deleterious variants. Where necessary, gene-editing approaches could be used to correct known harmful mutations.”
Implications for Future Cloning Applications
The possibility that the cloning process itself induces mutations introduces further complexities, potentially rendering standard donor cell screening insufficient. It is crucial to note that these research findings do not inherently render cloning techniques too risky for all applications. The rate of mutation per generation, while increased, remains relatively low. Furthermore, cells can be screened post-cloning to identify and manage potential genetic anomalies.
Nevertheless, the study reveals that the challenges associated with cloning technology are more extensive than previously understood. The existing complexities of cloning have been further amplified by this new evidence, suggesting a need for heightened caution and continued research in the field.